High dose melphalan, BCNU and etoposide with autologous bone marrow transplantation for Hodgkin's disease.

Thirty-eight patients with previously treated Hodgkin's disease were given high dose combination chemotherapy using melphalan and BCNU and autologous bone marrow transplantation. In 25 patients etoposide was added in conventional dosage. During the course of the study the dose of melphalan was...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Zulian, G. B., Selby, P., Milan, S., Nandi, A., Gore, M., Forgeson, G., Perren, T. J., McElwain, T. J.
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 1989
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2247129/
https://ncbi.nlm.nih.gov/pubmed/2653400
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars